We are live on ! Find out more
WM

WS Management Portfolio holdings

AUM $1.13B
1-Year Est. Return 53.44%
This Fund
S&P 500
This Quarter Est. Return
+10.62%
1 Year Est. Return
+53.44%
3 Year Est. Return
+163.58%
5 Year Est. Return
+226.76%
10 Year Est. Return
+868.14%
AUM
$1.01B
AUM Growth
+$49.3M
Cap. Flow
-$28.6M
Cap. Flow %
-2.83%
Top 10 Hldgs %
57.96%
Holding
79
New
15
Increased
4
Reduced
16
Closed
5

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$6.41M
2
HA
Hawaiian Holdings, Inc.
HA
+$5.8M
3
FSR
Fisker Inc.
FSR
+$4.14M
4
NFLX icon
Netflix
NFLX
+$4.09M
5
GME icon
GameStop
GME
+$3.88M

Sector Composition

Rank Sector Weight
1 Financials 19.28%
2 Communication Services 16.07%
3 Technology 13.37%
4 Materials 6.78%
5 Industrials 4.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRAA icon
51
PRA Group
PRAA
$679M
$3.16M 0.31%
82,048
CRSP icon
52
CRISPR Therapeutics
CRSP
$4.65B
$3.06M 0.3%
18,876
XOM icon
53
ExxonMobil
XOM
$643B
$3.05M 0.3%
48,301
WKHS icon
54
CALL
Workhorse Group
WKHS
$30.4M
$2.99M 0.29%
60
+27
+82% +$1,000K
AMZN icon
55
Amazon
AMZN
$2.5T
$2.98M 0.29%
17,340
SLB icon
56
SLB Ltd
SLB
$76.6B
$2.79M 0.28%
87,199
BMRN icon
57
BioMarin Pharmaceuticals
BMRN
$11.7B
$2.58M 0.25%
30,953
RIDE
58
DELISTED
Lordstown Motors Corp. Class A Common Stock
RIDE
$2.32M 0.23%
+13,967
New +$2.15M
DAL icon
59
Delta Air Lines
DAL
$56.6B
$2.02M 0.2%
46,711
SRPT icon
60
Sarepta Therapeutics
SRPT
$1.72B
$1.98M 0.2%
25,485
BRK.B icon
61
Berkshire Hathaway Class B
BRK.B
$1.07T
$1.71M 0.17%
6,167
WKHS icon
62
PUT
Workhorse Group
WKHS
$30.4M
$1.66M 0.16%
33
-17
-34% -$630K
EDIT icon
63
Editas Medicine
EDIT
$416M
$1.63M 0.16%
28,797
RARE icon
64
Ultragenyx Pharmaceutical
RARE
$2.67B
$1.51M 0.15%
15,885
TAL icon
65
PUT
TAL Education Group
TAL
$5.87B
$1.26M 0.12%
+50,000
New +$2.23M
ADVM
66
DELISTED
Adverum Biotechnologies
ADVM
$1.08M 0.11%
30,744
-40,000
-57% -$2.15M
VMEO
67
DELISTED
Vimeo
VMEO
$980K 0.1%
+20,000
New +$920K
SGMO
68
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$965K 0.1%
80,650
CLLS
69
Cellectis
CLLS
$286M
$788K 0.08%
50,907
ADAP
70
DELISTED
Adaptimmune Therapeutics
ADAP
$492K 0.05%
115,602
BLUE
71
DELISTED
bluebird bio
BLUE
$359K 0.04%
866
WVE icon
72
Wave Life Sciences
WVE
$1.15B
$285K 0.03%
42,722
NKLA
73
DELISTED
Nikola Corporation Common Stock
NKLA
$181K 0.02%
+333
New +$139K
ABEO icon
74
Abeona Therapeutics
ABEO
$351M
$144K 0.01%
3,696
BHP icon
75
PUT
BHP
BHP
$213B
-84,075
Closed -$5.2M

Similar funds

WS Management's Q2 2021 Portfolio in Review

As of Q2 2021, WS Management held 79 positions worth $1.01B, up 5.1% from $964M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

WS Management's Q2 2021 filing shows 15 new, 4 increased, 16 reduced and 5 closed positions. Its largest new stake was Fisker Inc.: 280,000 shares worth $5.4M. The largest sale was Micron Technology, an estimated $33.7M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 19% a quarter earlier, followed by Communication Services and Technology.

  • WS Management's largest Q2 2021 buy was Fisker Inc.: 280,000 shares worth $5.4M.
  • WS Management added most to NVIDIA in Q2 2021, an estimated $6.41M increase.
  • WS Management's biggest Q2 2021 reduction was Micron Technology, cutting an estimated $33.7M.
  • WS Management fully exited Capri Holdings in Q2 2021, selling an estimated $2.65M.
  • WS Management's ten largest holdings make up 58% of its $1.01B portfolio in Q2 2021.
  • WS Management opened 15 new positions and closed 5 in Q2 2021.
  • WS Management's portfolio value rose 5.1% quarter-over-quarter to $1.01B.

Based on WS Management's 13F filing for Q2 2021, filed 12 Aug 2021.